Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000993259 | SCV001146088 | uncertain significance | not provided | 2018-11-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001058764 | SCV001223356 | uncertain significance | DiGeorge syndrome | 2025-01-15 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 437 of the TBX1 protein (p.Pro437Ser). This variant is present in population databases (rs201993443, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of DiGeorge syndrome (PMID: 30773290). ClinVar contains an entry for this variant (Variation ID: 805626). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
New York Genome Center | RCV001058764 | SCV001468743 | uncertain significance | DiGeorge syndrome | 2019-07-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000993259 | SCV001805185 | likely benign | not provided | 2021-05-20 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30773290) |